Credit: Wake Forest School of Medicine
David R. Soto-Pantoja, Ph.D., associate professor of surgery and cancer biology at Wake Forest School of Medicine, and Elizabeth Stirling, graduate student, were part of a team of researchers who discovered blood biomarkers that can potentially predict patient response to immunotherapy for melanoma.